Home › Chronic Lymphocytic Leukemia › New Jersey › Newark
Chronic Lymphocytic Leukemia clinical trials in Newark, NJ
4 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Morristown Medical Center, Morristown · 17 mi away
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecruitingPhase 3
- Carol G Simon Cancer Center, Morristown · 17 mi away
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RecruitingPhase 1/2
- Atlantic Health, Morristown · 17 mi away
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
RecruitingPhase 2
- Summit Medical Group, Florham Park · 12 mi away
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Cincinnati, OH14 studies
- Chicago, IL14 studies
Other studies in Newark
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer14 studies
- Spinal Cord Injuries13 studies
- Acute Myeloid Leukemia12 studies
- Metastatic Cancer10 studies
- Heart Failure10 studies
- Pancreatic Cancer9 studies
- Cardiovascular Disease9 studies
- Melanoma8 studies
- Lung Cancer7 studies
- Cancer (all types)7 studies
- Crohn's Disease7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.